The activation of NF-κB, which is a principle indication of inflammatory response and is often observed in malignant tumors including breast, ovarian, and lung cancer [44, 45], could be a missing link between inflammation and cancer [46]. The gene discussed is NFKB1; the disease is lung carcinoma.